RegaDB pieter.libin@uz.kuleuven.be Bonn, Arevir Meeting April 23 rd - - PowerPoint PPT Presentation
RegaDB pieter.libin@uz.kuleuven.be Bonn, Arevir Meeting April 23 rd - - PowerPoint PPT Presentation
RegaDB pieter.libin@uz.kuleuven.be Bonn, Arevir Meeting April 23 rd , 2008 Introduction RegaDB Viral Data and Analysis Management environment HIV-1, HIV-2, HCV To be used by Clinicians Researchers Two main usage scenarios: Runs locally
Pieter Libin, 23/04/09
Introduction
RegaDB
Viral Data and Analysis Management environment
HIV-1, HIV-2, HCV
To be used by
Clinicians Researchers
Two main usage scenarios:
Runs locally
On a server in your institute On your local machine
On a collaboration server Easy access with Web browser
Pieter Libin, 23/04/09
Objective
A free and open-source database system Target audiance
Clinicians Researchers
Pieter Libin, 23/04/09
Objective (Clinicians)
Empower clinicians with analysis tools
Patient history graph Sequence analyses
HIV typing and subtyping Genotypic analyses for resistance interpretation
Third party analyses as “web services” Resistance reports
Pieter Libin, 23/04/09
Objective (Researchers)
Collaboration
Facilitate research collaborations Easily interchange data, keeping track of data origin Create collaborative databases keeping track of dataset versions Easily publish data sets to Stanford HIVDB
Publishing analyses tools
eg.: Tropism prediction tools
Querying
Visual Query Tool
Pieter Libin, 23/04/09
Data entities
Patient Therapy Dataset Test Viral Isolate Attribute Event
Pieter Libin, 23/04/09
Attributes
Annotate Patient with information
Adapts to “your (research) interest” Typically clinical and epidemiological information
Examples
Gender HIV transmission risk group Most of information collected in Collaborative projects WIV related information
Attributes can be grouped
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Viral Isolates
Viral Isolates Insertion Nucleotide Sequence Amino Acid Sequence Mutation Protein Information automatically inferred A N A L Y S E S
Pieter Libin, 23/04/09
Analysis services
Built-in services
Codon correct alignment based on the appropriate reference genome REGA Subtype tool Stanford ASI genotypic resistance algorithms
ANRS, HIVDB, REGA HIV-1/HIV-2
Resistance report generation
Using your own template documents
Integrate with external analysis services
Using “web services”
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Therapy
Consists of drug combination
commercial or generic representation dosage information
Start & end date Stop motivation
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Tests
Test (in a general sense) performed at a certain moment in time May be related to a
Viral Isolate Drug Combination of a viral isolate and a drug
Adapts to “your (research) interest”
Pieter Libin, 23/04/09
Tests
Tests on a sample:
CD4 count Viral Load count
Tests on a sample with respect to a drug
Therapeutic drug monitoring
Tests on a viral isolate:
HIV typing and subtyping
Tests on a viral isolate with respect to a drug
Genotypic/phenotypic resistance test
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Events
Start and end date Value (comparable to test values) eg.: Aids Defining Events
Pieter Libin, 23/04/09
Patient history chart
Pieter Libin, 23/04/09
Visual Query Tool
Hierarchical query builder
export results to csv file query database without the knowledge of SQL
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09
Pieter Libin, 23/04/09